{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiheydgltglbdwdasvvk7fnzl7rbzzhwnooz4hrll57b4bmgwvlo4q",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3miiclg6aa5z2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreihs4yniv5gslv4xxwpwazmdqvpsj3sble4olz6hvbzdguafle3ihy"
    },
    "mimeType": "image/jpeg",
    "size": 123080
  },
  "path": "/pharmalot/2026/04/01/fda-compounding-peptides-iran-war-trial-recruitment/?utm_campaign=rss",
  "publishedAt": "2026-04-01T13:19:42.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Pharma",
    "Pharmalot",
    "pharmalittle",
    "STAT+"
  ],
  "textContent": "The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns",
  "title": "STAT+: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more",
  "updatedAt": "2026-04-01T13:19:47.000Z"
}